Teva Pharmaceutical Industries Limited (FRA:TEV)

Germany flag Germany · Delayed Price · Currency is EUR
27.80
+1.10 (4.12%)
At close: Jan 29, 2026
54.44%
Market Cap32.91B +36.0%
Revenue (ttm)14.70B +4.3%
Net Income1.20B
EPS1.03
Shares Outn/a
PE Ratio27.40
Forward PE12.42
Dividendn/a
Ex-Dividend Daten/a
Volume4,236
Average Volume2,888
Open27.20
Previous Close26.70
Day's Range27.10 - 27.80
52-Week Range11.15 - 29.60
Betan/a
RSI56.73
Earnings DateJan 28, 2026

About FRA:TEV

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com... [Read more]

Industry Pharmaceutical Preparations
Founded 1901
Employees 37,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol TEV
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements